Craig-Hallum Maintains QuidelOrtho(QDEL.US) With Buy Rating
Analysts Conflicted on These Healthcare Names: QuidelOrtho (QDEL) and Enliven Therapeutics (ELVN)
William Blair Maintains QuidelOrtho(QDEL.US) With Hold Rating
QuidelOrtho Is Maintained at Underweight by JP Morgan
QuidelOrtho Analyst Ratings
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Cuts Target Price to $25
J.P. Morgan Keeps Their Sell Rating on QuidelOrtho (QDEL)
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $60
QuidelOrtho (QDEL) Gets a Buy From RBC Capital
QuidelOrtho Is Maintained at Outperform by RBC Capital
Raymond James Maintains QuidelOrtho(QDEL.US) With Buy Rating, Cuts Target Price to $60
QuidelOrtho Analyst Ratings
Craig-Hallum Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $60
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL) and GE Healthcare Technologies Inc (GEHC)
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Cuts Target Price to $61
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $64
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and QuidelOrtho (QDEL)
RBC Capital Sticks to Their Buy Rating for QuidelOrtho (QDEL)
QuidelOrtho Raised to Buy From Neutral by Citigroup
Citi Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $50